Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4534760014 | Darunavir propylene glycolate | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4534761013 | Darunavir propylene glycolate (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Darunavir propylene glycolate | Is a | Carbamate ester | true | Inferred relationship | Existential restriction modifier | ||
| Darunavir propylene glycolate | Is a | Sulfonamide | true | Inferred relationship | Existential restriction modifier | ||
| Darunavir propylene glycolate | Has disposition | Protease inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Darunavir propylene glycolate | Is modification of | Darunavir | true | Inferred relationship | Existential restriction modifier | ||
| Darunavir propylene glycolate | Is a | Substance with protease inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Darunavir propylene glycolate | Is a | Anti-infective agent | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely darunavir (as darunavir propylene glycolate) 800 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Darunavir propylene glycolate | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR